Extracellular matrix accumulation in immune-mediated tubulointerstitial injury.

[1]  L. Feng,et al.  Dysfunction of glomerular fibrinolysis in experimental antiglomerular basement membrane antibody glomerulonephritis. , 1993, Journal of the American Society of Nephrology : JASN.

[2]  Y. Xia,et al.  LPS-induced MCP-1, IL-1 beta, and TNF-alpha mRNA expression in isolated erythrocyte-perfused rat kidney. , 1993, The American journal of physiology.

[3]  L. Matrisian.  The matrix‐degrading metalloproteinases , 1992, Journal of neuro-oncology.

[4]  C. Alpers,et al.  Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor , 1992, The Journal of experimental medicine.

[5]  M. Post,et al.  Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. , 1991, Kidney international.

[6]  K. Suzuki,et al.  Substrate specificities and activation mechanisms of matrix metalloproteinases. , 1991, Biochemical Society transactions.

[7]  D. Auble,et al.  The AP-1 sequence is necessary but not sufficient for phorbol induction of collagenase in fibroblasts. , 1991, Biochemistry.

[8]  B. Wasylyk,et al.  The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins. , 1991, The EMBO journal.

[9]  D. Skup,et al.  Increased collagenase activity in metastatic cells as a result of decreased TIMP expression. , 1991, The Journal of rheumatology. Supplement.

[10]  R. Medcalf,et al.  Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Sporn,et al.  Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 , 1990, Nature.

[12]  T. Curry,et al.  Alpha 2-macroglobulin and tissue inhibitor of metalloproteinases: collagenase inhibitors in human preovulatory ovaries. , 1990, Endocrinology.

[13]  J. Mimuro.  [Type 1 plasminogen activator inhibitor]. , 1990, Rinsho byori. The Japanese journal of clinical pathology.

[14]  J. McPherson,et al.  Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. , 1989, The Journal of clinical investigation.

[15]  M. Laiho,et al.  Growth factors in the regulation of pericellular proteolysis: a review. , 1989, Cancer research.

[16]  A. Eisen,et al.  Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Sobel,et al.  Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor. , 1988, The Journal of biological chemistry.

[18]  W. Mckeehan,et al.  Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Moscatelli,et al.  The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells , 1987, The Journal of cell biology.

[20]  J. Heath,et al.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. , 1987, The EMBO journal.

[21]  D. Swann,et al.  The effect of platelet-derived growth factor on cell division and glycosaminoglycan synthesis by human skin and scar fibroblasts. , 1987, The Journal of investigative dermatology.

[22]  L. Matrisian,et al.  The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Presta,et al.  Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration , 1986, Molecular and cellular biology.

[24]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[26]  Z. Werb,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.

[27]  J. Quigley,et al.  The extracellular matrix of normal chick embryo fibroblasts: its effect on transformed chick fibroblasts and its proteolytic degradation by the transformants , 1985, The Journal of cell biology.

[28]  D. Loskutoff,et al.  Immunoradiometric assay to measure the binding of a specific inhibitor to tissue-type plasminogen activator. , 1985, The Journal of laboratory and clinical medicine.

[29]  S. Teitelbaum,et al.  Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. , 1985, The Journal of clinical investigation.

[30]  E. Bauer,et al.  Stimulation of in vitro human skin collagenase expression by platelet-derived growth factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[31]  B. Hazleman,et al.  The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. , 1983, The Biochemical journal.

[32]  A. Eisen,et al.  A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. , 1979, The Journal of biological chemistry.

[33]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[34]  C. Wilson,et al.  Interstitial nephritis in rats immunized with heterologous tubular basement membrane. , 1974, Kidney international.

[35]  L. Matrisian,et al.  Metalloproteinases and their inhibitors in matrix remodeling. , 1990, Trends in genetics : TIG.

[36]  G. González-Ávila,et al.  Experimental diffuse interstitial renal fibrosis. A biochemical approach. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[37]  K. Danø,et al.  Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.